Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shenzhen YHLO Biotech CoSHSE:688575 -3.14%66 5-Year Yield-on-Cost % is 0.22 as of Aug. 23, 2026, which is 88% below its 10-year median of 1.85. GuruFocus rates SHSE:688575 with a GF Score™ of 66/100 and a GF Value™ of ¥14.90 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 315 Medical Devices & Instruments companies, Shenzhen YHLO Biotech Co ranks worse than 94.92% on this metric.
The historical rank and industry rank for Shenzhen YHLO Biotech Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:688575'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.22 Med: 1.85 Max: 2.91
Current: 0.22
During the past 9 years, Shenzhen YHLO Biotech Co's highest Yield on Cost was 2.91. The lowest was 0.22. And the median was 1.85.
SHSE:688575's 5-Year Yield-on-Cost % is ranked worse than 94.92% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.38
vs SHSE:688575: 0.22
Shenzhen YHLO Biotech Co (SHSE:688575) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Shenzhen YHLO Biotech Co 5-Year Yield-on-Cost % Related Terms
SHSE:688575 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Shenzhen YHLO Biotech Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen YHLO Biotech Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen YHLO Biotech Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Shenzhen YHLO Biotech Co's 5-Year Yield-on-Cost % falls into.
Shenzhen YHLO Biotech Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Shenzhen YHLO Biotech Co (SHSE:688575) has a 5-Year Yield-on-Cost % of 0.22 as of Aug. 23, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shenzhen YHLO Biotech Co and its competitors. This is 88% below median its historical median of 1.85. Over the past decade, Shenzhen YHLO Biotech Co's 5-Year Yield-on-Cost % has ranged from 0.22 to 2.91. According to the industry distribution chart, Shenzhen YHLO Biotech Co ranks #299 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 94.9%.
Is Shenzhen YHLO Biotech Co's 5-Year Yield-on-Cost % too high?
Shenzhen YHLO Biotech Co's current 5-Year Yield-on-Cost % of 0.22 is 88% below median its 10-year median of 1.85. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 2.91. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.38. Shenzhen YHLO Biotech Co's value of 0.22 is 90.8% below this industry median. Based on the distribution chart, Shenzhen YHLO Biotech Co ranks #299 out of 315 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shenzhen YHLO Biotech Co has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen YHLO Biotech Co's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen YHLO Biotech Co ranks #299 out of 315 companies for 5-Year Yield-on-Cost %. This places Shenzhen YHLO Biotech Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.38. Shenzhen YHLO Biotech Co's value of 0.22 is 90.8% below this benchmark. Historically, Shenzhen YHLO Biotech Co's own 5-Year Yield-on-Cost % has ranged from 0.22 to 2.91 over the past decade. While the company's 10-year median is 1.85 vs. the industry median of 2.38, Shenzhen YHLO Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.38, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen YHLO Biotech Co's current 5-Year Yield-on-Cost % of 0.22 is 90.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shenzhen YHLO Biotech Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen YHLO Biotech Co's current 5-Year Yield-on-Cost % is 0.22, which is 88% below median its own 10-year median of 1.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen YHLO Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co (SHSE:688575) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥14.90, compared to a current price of ¥9.55 — trading 35.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.22, which is 88% below median its 10-year median of 1.85 and 90.8% below the Medical Devices & Instruments industry median of 2.38. Shenzhen YHLO Biotech Co's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Shenzhen YHLO Biotech Co (SHSE:688575), the current 5-Year Yield-on-Cost % is 0.22 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen YHLO Biotech Co (SHSE:688575) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen YHLO Biotech Co stock appears to be undervalued.
The current stock price of ¥9.55 is trading 35.9% below its estimated GF Value™ of ¥14.90.
GuruFocus considers Shenzhen YHLO Biotech Co to be Significantly Undervalued.
Key valuation signals for SHSE:688575:
5-Year Yield-on-Cost %: 0.22 (88% below median its 10-year median of 1.85)
GF Value™: ¥14.90 vs. price of ¥9.55 (35.9% below fair value)
Industry Position: 90.8% below the Medical Devices & Instruments median (#299 of 315)
No single metric tells the full story. See the SHSE:688575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
66GF Score
Get the complete analysis for SHSE:688575
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688575 has been successfully added to your 
